Nostrum Biodiscovery joins forces with Grifols and IrsiCaixa in the fight against COVID-19

Nostrum BioDiscovery team
Nostrum BioDiscovery team

Several media have reported on the collaboration of Nostrum Biodiscovery, a company cofounded by IRB Barcelona researcher Modesto Orozco, with Grifols and IrsiCaixa. This spin-off company from IRB Barcelona will contribute to research into COVID-19 by providing data that will facilitate the intelligent design of drugs in silico for the treatment of coronavirus.

The company has issued a press release to announce this collaboration and the appointment of its new CEO, Ezequiel Mas del Molino. Nostrum Biodiscovery thus begins a new period marked by an ambitious growth plan in which it will strengthen its present in the European and US markets.

Link to: Expansión

Link to: Europa Press

Link to: Siglo XXI

Link to: La Vanguardia